BCDA

Latest SEC Filings & News for BCDA

2 most recent filings and news items mentioning BCDA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/BCDA/news?limit=20"

Pull BCDA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OfferingJun 8, 2026Positive

BioCardia raises $4.4M in financing to extend cash runway into Q1 2027

BioCardia sold 3.5M shares at $1.279 per share on June 5, 2026, raising $4.4M in net proceeds. The capital is intended to fund operations through Q1 2027 and support the company's Japan PMDA submission for its CardiAMP cell therapy platform.

View filing at SEC.gov →

RegulatoryJun 5, 2026Positive

FDA confirms CardiAMP HF II trial may support premarket approval for heart failure therapy

BioCardia received FDA confirmation that its ongoing CardiAMP Heart Failure II trial may support premarket approval for its cell therapy treating ischemic heart failure. The positive FDA feedback potentially clears a major regulatory hurdle for a therapy targeting over one millio

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.